Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1Phase 2 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4INDUSTRY 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 3Non Small Cell Lung Carcinoma NSCLC 1Lung Neoplasms 1

Interventions

pembrolizumab 282Carboplatin 217Cisplatin 147Gemcitabine 146Paclitaxel 142Bevacizumab 116Pemetrexed 114Docetaxel 101Oxaliplatin 79durvalumab 78Dexamethasone 77Fluorouracil 76atezolizumab 75Nivolumab 75Cyclophosphamide 74130-nm albumin-bound paclitaxel 71Fulvestrant 70Capecitabine 64Cetuximab 63Injections 62Leucovorin 60Rituximab 55fludarabine 50Lenalidomide 50venetoclax 44Prednisone 43Irinotecan 42Letrozole 40enzalutamide 39tislelizumab 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × CP protocol × 90 days × Clear all
NCT05061550 2026-05-22

NeoCOAST-2

AstraZeneca

Phase 2 Recruiting
630 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07365319 2026-05-20

TeLuRide-008

Eikon Therapeutics

Phase 2/3 Recruiting
750 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02453282 2026-05-12

MYSTIC

AstraZeneca

Phase 3 Active not recruiting
1,118 enrolled 40 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02542293 2026-05-01

NEPTUNE

AstraZeneca

Phase 3 Active not recruiting
953 enrolled 29 charts
Thoracic

Non Small Cell Lung Carcinoma NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡